The Expert Angle

This study will provide an integrated data source to inform follow-up clinical care pathways for cancer survivors in Alberta The odds of long-term recovery from cancer have never been better. In the 1940s only 25% of Canadians survived a cancer diagnosis, compared with 60% ...

Studies on the costs of Huntington’s Disease are lacking in Canada. A real-world evidence study will be vital to future economic analyses.

Obesity has traditionally been considered a result of lifestyle factors, including poor diet and physical inactivity, and thus, it has been considered a preventable condition. However, the Canadian Medical Association has recently declared obesity to be a chronic medical disease due to the associated negative health effects.9 While lifestyle modifications can prevent obesity in some, further pharmaceutical intervention is required to mitigate the growing obesity epidemic in Canada and reduce the national burden of disease.

Real World Radar by Medlior, houses real world databases from across the world. Real world data provides chances for real world evidence to improve care

In Canada, approximately 1,700 men and 1,200 women were diagnosed with multiple myeloma (MM) in 2017. While this only corresponds to 1.6% and 1.2% of new cancer cases each year, the approximate five-year net survival rate according to the Canadian Cancer Society (estimated for the years ...

Medlior continues to have our work featured in respected publications and this month we’re pleased to be published in Future Oncology. Our manuscript looks at First-line treatment of advanced epidermal growth factor receptor mutation positive non-small cell lung cancer: A systematic review and network meta-analysis. Read more here.

Since 2008, when Founder Tara Cowling started Medlior Health Outcomes Research, we have grown by leaps and bounds. The Medlior team now has 15 full-time staff with another 40 regular contractors - all of whom hold advanced degrees - that allow us to offer a range of research services ...

During the 2019 annual HTAi meeting in Cologne, Germany, Medlior’s Kelly Larkin-Kaiser along with Peter O’Blenis and Jennifer Tetzlaff from Evidence Partners hosted a workshop titled: “Best Practices for Leveraging Artificial Intelligence in the Systematic Review Process” The workshop focused ...

Gene therapy is a growing area of interest for the treatment of several diseases. These therapies are intended to offer a one-time treatment to modify a person’s genes through a variety of mechanisms in order to treat or cure a disease.  These mechanisms include: i) replacing the gene with a ...